⌕
Novanta · NOVT · Nasdaq
Tenet 33 · Weak
Compare
$115.33+0.81%At closeTenet 33 · Weak
$115.33+0.93 (+0.81%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Novanta (NOVT) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is NOVT's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Seeking AlphaNov 10, 2026 · 15:31 ET
Novanta Inc. (NOVT) Q3 2026 Earnings Call Transcript

Novanta Inc. ( NOVT ) Q3 2026 Earnings Call November 10, 2026 8:00 AM EST Company Participants Marcella Meditz Matthijs Glastra - CEO & Chairman of the Board John Lesica - Co-Chief Operating Officer of Medical Solutions …

NOVT +0.8% todayRead at source ↗
● MarketBeatNov 10, 2026 · 13:17 ET
What Novanta (NOVT) Said on Its Q3 Earnings Call

Novanta NASDAQ: NOVT reported third-quarter revenue growth of 23% and its strongest organic growth in more than three years, as demand for robotics and advanced manufacturing products helped offset weakness in precision …

NOVT +0.8% todayRead at source ↗
● Business WireNov 10, 2026 · 12:24 ETCOMPANY'S OWN WORDS
Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executiv…

NOVT +0.8% todayRead at source ↗
● Zacks Investment ResearchNov 9, 2026 · 19:36 ET
Novanta (NOVT) Q3 Earnings and Revenues Surpass Estimates

Novanta (NOVT) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.87 per share a year ago.…

NOVT +0.8% todayRead at source ↗
● Business WireNov 9, 2026 · 16:45 ETCOMPANY'S OWN WORDS
Novanta Announces Financial Results for the Third Quarter 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third q…

NOVT +0.8% todayRead at source ↗
● Business WireOct 20, 2026 · 15:02 ETCOMPANY'S OWN WORDS
Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer,…

NOVT +0.8% todayRead at source ↗
● Business WireOct 13, 2026 · 17:00 ETCOMPANY'S OWN WORDS
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close o…

NOVT +0.8% todayRead at source ↗
● Defense WorldOct 5, 2026 · 02:58 ET
Eltek (NASDAQ:ELTK) vs. Novanta (NASDAQ:NOVT) Financial Survey

Eltek (NASDAQ: ELTK - Get Free Report) and Novanta (NASDAQ: NOVT - Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earning…

NOVT +0.8% todayRead at source ↗
● Defense WorldSep 24, 2026 · 04:15 ET
Analyzing Senstar Technologies (NASDAQ:SNT) and Novanta (NASDAQ:NOVT)

Novanta (NASDAQ: NOVT - Get Free Report) and Senstar Technologies (NASDAQ: SNT - Get Free Report) are both technology companies, but which is the superior business? We will compare the two businesses based on the strengt…

NOVT +0.8% todayRead at source ↗
● Defense WorldSep 1, 2026 · 03:58 ET
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in Novanta Inc. $NOVT

Connor Clark and Lunn Investment Management Ltd. acquired a new position in Novanta Inc. (NASDAQ: NOVT) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). Th…

NOVT +0.8% todayRead at source ↗
● Business WireAug 28, 2026 · 17:00 ETCOMPANY'S OWN WORDS
Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer,…

NOVT +0.8% todayRead at source ↗
● Zacks Investment ResearchAug 18, 2026 · 09:55 ET
Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.…

NOVT +0.8% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA29−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just NOVT · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.